Session Information
Clinical Nutrition Week 12
Click here to go to the previous page
The Dynamic Milieu of the Gut
Track
:
Gut Microbiota
Program Code:
S22
Date:
Sunday, January 22, 2012
Time:
10:30 AM to 12:30 PM
EST
Location:
Northern Hemisphere Salon D + Corridor
COORDINATOR
:
Gail Cresci, PhD, RD, CNSD, LD
MODERATOR
:
Gail Cresci, PhD, RD, CNSD, LD, Staff Researcher, Gastroenterology/Hepatology Department, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH
PRESENTER
(S):
Gail Cresci, PhD, RD, CNSD, LD, Staff Researcher, Gastroenterology/Hepatology Department, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH
Vadivel Ganapathy, PhD
Daniel Teitelbaum, MD
PRESENTER/MODERATOR
(S):
Gail Cresci, PhD, RD, CNSD, LD, Staff Researcher, Gastroenterology/Hepatology Department, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH
Gail Cresci, PhD, RD, CNSD, LD
Daniel Teitelbaum, MD
Vadivel Ganapathy, PhD
SUBMITTER
:
Gail Cresci, PhD, RD, CNSD, LD
Description
1. Describe the role of colonic fermentation products in reducing the risk for colon cancer and liver disease
2. Explain how SLC5A8 (a transporter for short-chain fatty acids) and GPR109A (a receptor for butyrate) mediate the tumor-suppressive functions of colonic fermentation products
3. Relate how the gut microbiota and its metabolic byproducts influence liver pathology
2. Explain how SLC5A8 (a transporter for short-chain fatty acids) and GPR109A (a receptor for butyrate) mediate the tumor-suppressive functions of colonic fermentation products
3. Relate how the gut microbiota and its metabolic byproducts influence liver pathology
Handout Online
(Code: S22)
This session is a part of:
This session is a part of:
